CPHI vs PARA
China Pharma Holdings Inc (CPHI) versus PARA (PARA) — a side-by-side from cached financials, not a winner call.
China Pharma Holdings Inc (CPHI) is a drug manufacturers - specialty & generic company listed on US.
PARA (PARA) common stock.
Latest reported CPHI revenue for 2025-12-31 was $4.1M. Net income was -$3.2M. Revenue was down 8.5% from 2024-12-31 to 2025-12-31. CPHI currently screens at market cap $29.0M.
PARA does not have a complete income-statement cache yet.
CPHI currently screens at market cap $29.0M. PARA currently screens at market cap $0.
Not investment advice. Open the CPHI and PARA stock pages for the full models.
Not investment advice.